Opportunity to make a difference, but unstable work environment - Anonymous employee Merck Employee Review

3.0
Sep 14, 2012
Anonymous employee
Recommend
CEO approval
Business Outlook

Pros

- Merck makes important medicines, such as its pediatric and adult vaccines. Manufacturing these medicines, and developing new medicines, is an important public health contribution. - Merck's strength is its organizational experience with clinical development and the regulatory environment, and in manufacturing of complicated medicines. - Lots of good experience to be had, in a variety of functional roles from discovery to development and manufacturing, from quality to regulatory to technical science and engineering jobs.

Cons

Merck is trying to re-invent itself as a low-cost manufacturer, and leader of the field, but all while minimizing the amount of money spent. Upper management turnover is quite high, and leads to a very unstable environment, with a high rate of change, and minimal acknowledgement of the challenges this brings. The implicit message is that employees should be happy to have a job, and they should suck it up and work harder.

Explore other reviews about Merck

5.0
Jun 30, 2026
Recommend
CEO approval
Business Outlook

Pros

Excellent company to work with.

Cons

No cons encountered so far

4.0
Jun 30, 2026
Recommend
CEO approval
Business Outlook

Pros

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Cons

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

See reviews by: Helpful|Rating|Date|All